Phase-III trials were conducted for safety, and immunogenicity in around 3,100 subjects, in 14 trial sites across India (supported by BIRAC)
Dapagliflozin reduces the risk of sustained eGFR, cardiovascular deaths and hospitalization for heart failure in adults with CKD
The two have agreed to jointly undertake R&D activities on scientific validation of Ayush concepts, procedures and products
The company's long-term strategy is on science, technology and innovation and the company's strategy relating to this is on track
The MoU will enable both countries to promote research collaboration and building capacities in the field of the Indian Ayurvedic system of traditional medicines
Investment further strengthens Merck's "Big 3," the key drivers for increasing Group sales to approximately € 25 billion by 2025
This dense phase often resembles liquid droplets exhibiting higher protein density and weaker molecular motion than the surrounding medium.
The Centre aims at promoting innovation among the scientific community to improve healthcare solutions around the globe
All claims made by Seagen regarding Daiichi Sankyo antibody drug conjugates are denied
Merck’s first microbiology application and training lab in India
Subscribe To Our Newsletter & Stay Updated
